Related Experiment Videos
Treatment toxicity reduction: breast cancer.
K Possinger1, H Wagner, P Langecker
1Med. Klinik III, Ludwig Maximilians Universtaet, Muenchen, F.R.G.
Cancer Treatment Reviews
|December 1, 1987
Summary
Tailoring chemotherapy to individual patient prognosis in advanced breast cancer is crucial. This approach optimizes treatment intensity, reducing toxicity while improving survival outcomes for high-risk groups.
Area of Science:
- Oncology
- Medical treatment
Background:
- Curative treatment for advanced breast cancer remains elusive.
- Reducing systemic treatment toxicity is paramount.
Purpose of the Study:
- To investigate a prognosis-oriented therapeutic strategy for metastatic breast cancer.
- To assess the impact of prognostic factors on chemotherapy effectiveness and survival.
Main Methods:
- Developed and applied a prognostic score to classify 475 metastatic breast cancer patients into 'high' and 'low' risk groups.
- Analyzed survival times based on prognostic groups and treatment response.
Main Results:
- Prognostic score effectively separated patients into distinct survival groups.
- Patients with unfavorable prognostic factors significantly benefited from chemotherapy, showing longer survival with stable disease or partial remission.
- Favorable prognostic groups showed similar survival regardless of response, except for complete remission.
Conclusions:
- Chemotherapy is essential for advanced breast cancer.
- Prognosis-guided chemotherapy administration can reduce toxicity and improve survival outcomes.
- Individualized treatment plans based on prognostic factors are key for managing metastatic breast cancer.